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ABSTRACT 
The aim of this study was to examine the risks for and time trends of first-time 
myocardial infarction and type 1 diabetes mellitus, and the equity of admission to 
specialized care and evidence-based treatments after first-time myocardial infarction in 
association with country of birth, socioeconomic position, sex, and age.  
 
The Migration & Health Cohort was used in all four papers. This cohort was built by 
linkage between Swedish national registers to study the incidences of cancer, diabetes, 
injuries, and cardiovascular and psychiatric diseases among immigrants and their 
descendants compared with Sweden-born residents. Poisson regression was used to 
estimate incidence rate ratio of first-time myocardial infarction and type 1 diabetes 
mellitus, logistic regression for odds ratio of admission to coronary care units, and Cox 
proportional hazard regression to model first-time myocardial infarction case fatality 
and likelihood of undergoing cardiac procedures. 
 
First, during more than two decades of follow-up of all men and women aged 35–89 
years living in Sweden, we identified 571,476 patients with first-time myocardial 
infarction (Paper I). We observed a decreasing trend in incidence and case fatality after 
day 28 for both sexes regardless of country of birth. The trend was, however, less 
pronounced among women and those born outside Sweden. Men born in Southern and 
Western Asia had a 50% higher risk than men born in Sweden. Incidence was 50–80% 
higher in the least well educated irrespective of sex and country of birth.  
 
Secondly, between 2001 and 2009 we identified 120,609 first-time myocardial 
infarction patients treated in a coronary care unit (Paper II).  A low rate of coronary 
care unit admission after first-time myocardial infarction among women and patients of 
low socioeconomic position was observed. Foreign-born patients, both men and 
women, were equally likely to be admitted to coronary care units as Sweden-born 
patients.  
 
Thirdly, we followed first-time myocardial infarction patients admitted to coronary care 
units between January 2001 and September 2009 for 90 days after admission (Paper 
III). In total, 61.71% of patients underwent angiography, 45.74% underwent 
percutaneous coronary intervention, and 9.15% underwent coronary artery bypass 
grafting. Foreign-born patients were no less likely to undergo these procedures than 
Sweden-born patient. Furthermore, patients born in Asia had a high rate of access to 
coronary artery bypass grafting.  
 
Fourthly, we followed 4,469,671 men and 4,231,680 women, aged 0 to 30 years, living 
in Sweden at any time between 1969 and 2008 (Paper IV). Over the study period, the 
risk of type 1 diabetes mellitus increased among children younger than 15 years, but 
not among young adults (15–30 years). Compared with Sweden-born individuals, 
immigrants aged 0 to 14 had about a 40% lower risk of type 1 diabetes mellitus, and the 
risk was about 25% lower in the offspring of immigrants. Further, immigrants aged 15 
to 30 years had about a 30% lower risk, and the offspring of immigrants about a15% 
lower risk of type 1 diabetes mellitus compared with their Sweden-born counterparts. 
 
Country of birth is associated with risk of first-time myocardial infarction and type 1 
diabetes mellitus. First-time myocardial infarction risk is decreasing in all age groups 
  
but type 1 diabetes mellitus is increasing among children less than 15 years of age. 
Immigrants in Sweden are not disadvantaged in terms of accessing cardiac care after 
first myocardial infarction, in contrast to women and patients with low socioeconomic 
position. 
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1 INTRODUCTION 
Cardiovascular diseases are considered to be the leading cause of mortality around the 
world
1
. Cardiovascular diseases are among the most important burdens of disease in the 
Swedish healthcare system with high costs for both the individual and society
2
. Of all 
cardiovascular diseases, myocardial infarction (MI) costs most years of life lost. The 
treatment of acute MI is costly. Sweden is among the countries with the highest 
incidence of type 1 diabetes mellitus (T1DM)
3
. It has been estimated that among 
children younger than 15 years the risk of T1DM is increasing in many countries and 
varies significantly by ethnicity
4, 5
. 
 
Sweden is a country that provides extremely good opportunities to conduct migration 
health research for several reasons. First, around 15% of the population in Sweden was 
born overseas, and immigrants are from almost all over the world
6
. Moreover, for more 
than 11% of the population born in Sweden, at least one parent was born overseas. 
Secondly, Sweden has relatively complete registers that include the majority of the 
Swedish population including immigrants. These registers cover many research areas 
such as demographic, socioeconomic, and medical information. Many of these registers 
date back several decades with reasonably high accuracy.  
 
The studies in this thesis are based on information from the newly established M&H Co 
(Figure 1).  This cohort is built by linkage between the 14 Swedish national registers. 
Linkage has been completed using the Swedish 10-digit unique personal identity 
number (PIN), which is maintained by the National Tax Board for all individuals who 
have resided in Sweden since 1947, by Statistics Sweden and the National Board of 
Health and Welfare.  
 
This thesis includes four register-based cohort studies including the entire Swedish 
population. We investigated the risk of first-time MI (fMI) and its trends over the last 
few decades by country of birth, education, and sex, as well as case fatality 28 days 
after fMI. We also compared the likelihood of admission to a coronary care unit (CCU) 
and of undergoing cardiac procedures among foreign-born and Sweden-born fMI 
patients. By using data from the M&H Co., the risk of T1DM and its trends in Sweden 
regarding country of birth, education, and sex were also evaluated. 
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2 BACKGROUND 
 
2.1 IMMIGRANTS IN SWEDEN 
There has been an ongoing trend of global movement of people, ideas, and services. 
Immigrants in Sweden are from almost all over world. In 2011, there were 1,437,296 
inhabitants of Sweden who were born abroad
7
. In addition, 1,096,976 persons were 
born in Sweden with at least one foreign-born parent
7
. With a total population of 
9,482,855, about 15% of the population was foreign born, 5% was born in Sweden with 
two parents born abroad, and 7% was born in Sweden with one parent born outside 
Sweden. In total, around 26% of the Swedish population had a immigrant background 
in 2011
7
. 
 
The number of immigrants in Sweden has been increasing in recent years and is 
expected to continue increasing in the future (Figure 2.1). In 2010, there were 
1,384,929 foreign-born Swedish residents, which corresponded to 14.3% of the total 
population
7
. Of these, 859,000 (9.2%) were born outside the European Union (EU) and 
477,000 (5.1%) were born in other EU member states
8
. The top 10 source countries of 
foreign-born individuals living in Sweden in 2010 were: Finland, the Former 
Yugoslavia, Iraq, Poland, Iran, Germany, Denmark, Norway, Turkey, and Somalia
9
.  
 
Sweden has become a country of net immigration from one of net emigration since 
World War II. A large number of refugees came to Sweden after the war. In 1946, there 
were more than 70,000 foreign-born residents of Sweden, which was four-fold higher 
than the number in 1940. From 1949 up to the 1970s, immigrants from Southern 
Europe and other Nordic countries due to establishment of the first common Nordic 
labor market. After the 1970s, the immigrant population again mainly consisted of 
refugees. At first, many refugees were from Chile after the military coup of 1973. At 
the beginning of the 1980s, refugees from the Middle East arrived after the Iran–Iraq 
war. In the 1990s, many asylum seekers fled to Sweden because of the Yugoslav Wars. 
In the 2000s, there were also large inflows of immigrants from the Middle East due to 
the Iraq war and from Africa
10
. 
  
In 2011 the overall numbers of male (694,815) and female immigrants (732,481) were 
similar
9
. There were 620,084 foreign-born men and 661,497 foreign-born women in 
2008. However, the gender distribution was uneven across the 10 main immigration 
source countries. For example, there were more men than women from Iraq, but more 
women from Finland and Poland
10
. 
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2.2 MYOCARDIAL INFACTION 
 
MI, also known as acute MI or heart attack, is the death or damage of heart muscle 
caused by interruption of blood flow to a part of the heart. It is commonly caused by 
occlusion of a coronary artery after the rupture of a vulnerable atherosclerotic plaque. A 
vulnerable atherosclerotic plaque is an unstable collection of white cells and lipids in 
the wall of an artery. The coronary arteries convey blood and oxygen to the heart. If the 
arteries are blocked and left untreated for a sufficient length of time, the resulting 
restriction in blood supply and shortage of oxygen can cause damage to or death of 
heart cells. 
 
2.2.1 Diagnostic criteria  
In 1979, the World Health Organization (WHO) formulated diagnostic criteria for MI: 
(1) history of ischemic type chest pain lasting for more than 20 minutes; (2) 
unequivocal changes in electrocardiography (ECG), the development of abnormal 
persistent Q or QS waves, and evolving injury lasting longer than 1 day; and (3) rise 
and fall of serum cardiac biomarkers such as creatine kinase-MB fraction and troponin. 
A diagnosis of MI was made if two of these three criteria were met
11
. 
 
In 2000, the European Society of Cardiology (ESC)/American College of Cardiology 
(ACC) criteria for redefinition of MI were established. A consensus document between 
the ESC and ACC was produced; either one of the two following criteria were required 
Figure 2.1: Population in 2000–2012 and forecast for 2013–2060 among Sweden- and foreign-born individuals 
(Source: Statistics Sweden) 
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for a diagnosis of acute MI: “(1) Typical rise and gradual fall (troponin) or more rapid 
rise and fall (CK-MB) of biochemical markers of myocardial necrosis with at least one 
of the following: (a) ischaemic symptoms; (b) development of pathologic Q waves on 
the ECG; (c) ECG changes indicative of ischaemia (ST segment 
elevation or depression); (d) coronary artery intervention (e.g., coronary 
angioplasty). (2) Pathologic findings of an acute MI.”12 The new guildelines placed 
more emphasis on cardiac biomarkers than in previous diagnostic criteria
12
.  
 
In 2007, the ESC and ACC collaborated with the American Heart Association (AHA) 
and the World Heart Federation (WHF) to produce a second document re-defining MI. 
Any of following criteria were required for a diagnosis for MI: “ (1) Detection of 
increase and/or decrease of biomarkers, preferably troponin, with at least one value 
above the 99
th
 percentile of the upper reference limit together with evidence of 
myocardial ischaemia with one at least following features: symptoms of ischaemia; 
ECG changes indicative of new ischaemia; development of pathological Q waves in the 
ECG; and imaging evidence of new loss of viable myocardium or new regional wall 
motion abnormality. (2) Sudden, unexpected cardiac death involving cardiac arrest, 
often with symptoms suggestive of myocardial ischeamia, accompanied by presumably 
new ST elevation, or new LBBB, and/or evidence of fresh thrombus by coronary 
angiography and/or at autopsy, but death before occurring before blood samples could 
be obtained, or at a time before the appearance before cardiac biomarkers in the blood. 
(3) For percutaneous coronary interventions (PCI) in patients with normal baseline 
troponin values, elevations of cardiac biomarkers above the 99
th
 percentile URL are 
indicative of peri-procedural myocardial necrosis. By convention, increases of 
biomarkers greater than 3×99
th
 percentile URL have been designated as defining PCI-
related myocardial infarction. A subtype related to a documented stent thrombosis is 
recognized. (4) For coronary artery bypass grafting (CABG) in patients with normal 
baseline troponin values, elevations of cardiac biomarkers above the 99
th
 percentile 
URL are indicative of peri-procedural myocardial necrosis. By convention, increases 
biomarkers greater than 5×99
th
 percentile URL plus either new pathological Q waves or 
new LBBB, or angiographically documented new graft or native coronary artery 
occlusion, or imaging evidence of new loss of viable myocardium have been designated 
as defining CABG-related myocardial infarction. 5) Pathological findings of an acute 
myocardial infarction.”13 
 
In 2011, the WHO accepted the universal definition of MI. The 2007 universal 
definition was not accepted due to concern that it was only suitable for use in Europe 
and North America, but not in other developing countries. Therefore at that time the 
WHO definition was developed
14
.  
 
In August 2012, the third universal definition of MI was presented and discussed
15
.  It 
was developed by the new Global Task Force, which consisted of 52 member states 
including new members such as China and Russia, in collaboration with ESC, ACC, 
AHA, and WHF. The third universal definition is also referred to by the US Food and 
Drug Administration as the basis for clinical trial protocols. Based on the second 
universal definition, a new consensus was reached regarding levels of troponin required 
for a diagnosis of PCI- and CABG-related MI, as well as the levels required for 
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diagnosing MI not due to cardiac procedures or due to cardiac procedures other than 
PCI and CABG.  
 
2.2.2 Classification 
In the clinical setting, patients with acute coronary syndrome based on the 12-lead ECG 
can be classified into two subgroups: those with new ST-elevation on the ECG that is 
diagnostic of acute ST-elevation MI and non-ST-elevation MI
16
.  
 
The Joint ESC/ACC/AHA/WHF Task Force for the Redefinition of Myocardial 
Infarction published the universal definition of MI
13
. Type 1: spontaneous MI that is 
related to ischemia and due to a primary coronary event such as plaque erosion, rupture, 
fissuring, or dissection; type 2: MI secondary to ischemia caused by either increased 
oxygen demand or decreased oxygen supply, such as coronary artery spasm, coronary 
embolism, anemia, arrhythmias, hypertension, or hypotension; type 3: MI resulting in 
death including cardiac arrest, often with symptoms suggestive of myocardial ischemia, 
accompanied by new ST elevation or new LBBB, or evidence of fresh thrombus in a 
coronary artery, but death occurring when biomarker values are unavailable (i.e. before 
blood samples could be obtained, at a time before cardiac biomarker levels could rise, 
or in rare cases because cardiac biomarkers were not collected); type 4: MI associated 
with PCI or stent thrombosis; type 5: MI associated with CABG. 
 
2.2.3 Epidemiology of MI 
There have been many studies to measure the incidence of MI across different 
populations and settings.  
 
The Framingham Heart Study is a prospective cohort study of cardiovascular disease 
and risk factors from a sample of the population of the town of Framingham, MA, 
USA. Trends in disease incidence and outcomes such as MI have been assessed in the 
Framingham Heart Study under the auspices of the Framingham Cardiovascular 
Disease Survey
17, 18
. Findings from the study have shown that the incidence of MI 
along with other manifestations of coronary disease decreased over a 20-year period.    
 
The WHO Multinational Monitoring of Trends and Determinants in Cardiovascular 
Disease (MONICA) project was created in the early 1980s to evaluate trends in 
cardiovascular diseases and associations with risk factor changes
19
. The results showed 
a wide variation across participating countries regarding MI incidence and case 
fatality
19, 20
.  
 
The Global Burden of Disease study was commissioned by the World Bank in 1991
21, 
22
. Its goal was to provide summary measures of mortality and morbidity across all 
world regions by using standardized measures of diseases, including MI. The incidence 
rates of MI were standardized according to age. The highest rates were observed in 
Eastern Europe and Central Asia. There was no significant variation between countries 
within each region. The overall incidence of MI was approximately two-fold higher in 
men than in women
23
.  
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The Reduction of Atherothrombosis for Continued Health (REACH) Registry is a 
prospective study
24
. Participants were enrolled from 5,587 physician practices in 44 
countries. A total of 61,332 patients were followed up between December 2003 and 
December 2004. It was found that a higher level of education was associated with a 
lower risk of cardiovascular events; however, there was no such association in low 
income countries, particularly for women
24
. 
 
The surveillance component of the Atherosclerosis Risk in Communities (ARIC) study 
was conducted to assess coronary heart disease incidence by ethnicity and by 
geographic location in the USA
25, 26
. There was no change in the incidence rate of 
hospitalization due to MI between 1987 and 1994. However, when stratified by 
ethnicity and sex, black women showed an increase risk of MI.  
 
Many other studies have evaluated trends in and risks of MI. For example, the 
Minnesota Heart Survey has been following up hospitalized MI patients among 
residents of the Minneapolis–St. Paul metropolitan area (MN–WI, USA) since the 
1970s 
27, 28
. The Corpus Christi Heart Project was designed to compare disease burden 
and outcome between Mexican Americans and Whites the USA
29, 30
. FINAMI is a 
population-based MI registry to evaluate MI and coronary heart disease death within 
several geographic areas in Finland
31
. The National Registry of Myocardial Infarction 
is a large observational study of acute MI in the USA. Since 1990, information has 
been collected on more than two million patients with a central focus on care 
management and short-term prognosis
32-34
. 
 
2.2.4 Risk factors 
Current smoking and hyperlipidemia
35
 are two of the strongest risk factors for MI
1, 36
. A 
strong and positive association was found between the number of cigarettes smoked 
and risk of MI. Those who smoked more than 40 cigarettes per day had an almost 10 
times higher risk than non-smokers
1
. Four other important risk factors were abdominal 
obesity (waist/hip ratio), history of diabetes, hypertension, and psychosocial factors
37
.  
Patients with diabetes have been found to have twice the risk of MI compared with the 
general population
38
. The presence of smoking, hypertension, and diabetes increased 
the risk of MI more than 13-fold compared with the absence of these risk factors
1
. 
Consumption of fruits/vegetables and moderate alcohol as well as regular physical 
activity have been found to be protective
38–41
. The combined effect of these three 
protective factors showed an almost 80% decreased risk of MI
1
, while incorporating all 
nine independent factors could increase the risk more than 100-fold compared with 
none of these risk factors
1
. These nine risk factors explain more than 90% of the 
population-attributable risk, suggesting that these risk factors could account for the 
majority of the MI risk in the study population
1
.   
 
An overall risk ratio of 1.6 was observed among rheumatoid arthritis patients compared 
with a matched general population
39
. Other inflammatory diseases such as 
atherosclerosis are also important risk factors for MI
40, 41
. Furthermore, family history 
of MI is associated with an increased risk of MI
42
. However, in one study it was found 
that the risk of a family history of MI could be explained by association with other 
major risk factors
1
.  
 8 
 
Human immunodeficiency virus was found to increase MI risk by 50%
43
. Rates of MI 
were shown to increase particularly following influenza outbreaks
44
. Low vitamin D 
levels were also associated with higher prevalence of cardiovascular disease risk factors 
and a higher risk of MI
45
.  The chronic systemic inflammation present in psoriasis was 
suggested to explain why moderate to severe psoriasis is an independent risk factor for 
MI
46
.  
 
Epidemiological and family studies have shown that genetic predisposition explains 
40% to 60% of the risk for coronary artery disease (CAD)
47
. For example, the locus at 
9q34.2 was associated with MI
47
. Two other gene variants in the leukotriene pathway 
(ALOX5AP and LTA4) have been found to be susceptibility factors for MI
48
. It has 
been suggested that genetic association studies of MI should also focus on 
multifactorial pathophysiology and interaction with environmental factors. For 
example, the findings of a large-scale genetic study including 352 MI cases and 418 
control subjects suggested a potential association between MI and three variants of the 
thrombospondin gene family
49
. In another study of 2819 MI cases and 2242 control 
subjects, a potential association was identified between MI and single-nucleotide 
polymorphisms in the connexin 37 and the plasminogen-activator inhibitor type 1 
genes
50
. The findings from some genetic studies of MI have been inconclusive 
47
.  
 
Risk factors might have a different impact on MI according to sex and country of birth. 
Similar risk among men and women was found for the associations between MI and 
smoking, hyperlipidemia, abdominal obesity, psychosocial factors, and fruit and 
vegetable consumption
1
. By contrast, hypertension, diabetes, regular exercise, and 
consumption of alcohol at least three times per week were more strongly associated 
with the risk of MI in women than men
1
. Most of the important risk factors for MI are 
consistently observed in most countries worldwide, including smoking, hyperlipidemia, 
hypertension, diabetes, abdominal obesity, and psychosocial factors
1
. 
 
2.2.5 Coronary angiography, PCI and CABG 
Coronary angiography is a procedure that is performed to visualize blood flow through 
the coronary arteries. A catheter (i.e. a long, thin, flexible tube) is passed through an 
artery and the tip is moved upward through the arterial system into the major coronary 
artery. An X-ray contrast agent is administered through the catheter at the site to be 
visualized. X-ray images are taken to visualize the size of the artery openings and 
highlight any blockages in blood flow. The procedure may last 30 to 60 minutes. 
 
PCI, also termed angioplasty, is a non-surgical procedure to open the narrowed or 
blocked coronary arteries of the heart. The coronary arteries narrow as a result of 
accumulation of cholesterol plaques caused by atherosclerosis. During the procedure, 
cardiologists use live X-ray imaging to guide the catheter from the inguinal femoral 
artery or radial artery to the site of the blockage in the heart. A deflated balloon or other 
device is pushed over the catheter. At the site of the blockage, the balloon is inflated in 
order to re-open the artery. Inflation of the balloon within the coronary artery crushes 
the plaque on the wall of the artery. Sometimes, a stent (i.e. a small mesh tube) is 
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placed permanently at the blockage site to keep the artery open. PCI with stenting is an 
alternative to heart surgery for some types of non-severe CAD. 
 
CABG is a surgical procedure performed to reduce the risk of mortality due to coronary 
heart disease. It bypasses narrowed or blocked arteries by grafting arteries or vessels 
from another part of the body to the coronary arteries. It improves blood supply to the 
coronary circulation supporting the myocardium.  CABG is usually conducted while 
the heart is stopped, using cardiopulmonary bypass. The procedure is often used when a 
patient has a blockage in one or more coronary arteries. 
 
2.3 TYPE 1 DIABETES MELLITUS   
T1DM is a heterogeneous disorder with main features including destruction of 
pancreatic beta cells, eventually causing absolute insulin deficiency. Most incidences 
are associated with an autoimmune-mediated destruction of beta cells (type 1a). 
However a small proportion of cases are attributable to an idiopathic destruction or 
failure of beta cells (type 1b). T1DM is the most common type of diabetes in children 
and adolescents even though type II diabetes is increasing among young populations
51
. 
T1DM accounts for about 5–10% of the total incidence of diabetes worldwide52. 
 
2.3.1 Epidemiology 
The WHO Multinational Project DIAMOND followed children up to 14 years of age in 
50 countries worldwide from 1990 to 1994
53, 54
. The age-adjusted incidence of T1DM 
ranged from 0.1 to 36.8/100,000 person-years. Countries with the lowest incidence 
included China and Venezuela, while those with highest incidence included Sardinia, 
Finland, Sweden, Norway, the UK, New Zealand, Canada, and Portugal. The incidence 
of T1DM in the US population in the study was approximately 10 to 20/100,000 
person-years. Further, the average incidence was estimated to be between 5 and 
10/100,000 person-years in about half of the populations from European countries 
included in the present study. The risk was increased with age, with the highest 
incidence found in the group aged 10 to 14 years. A higher risk among boys than girls 
was also reported in some countries. Moreover, there was a positive association 
between rapid social change and variation in T1DM risk profile. In the DIAMOND 
project, the temporal trend in incidence was also assessed during the period from 1990 
to 1999. The overall increase in annual incidence was about 2.8% within the study 
period. The rate of increase accelerated to about 3.4% in the second half of the study 
period compared to 2.4% in the first half. Similar increasing temporal trends were 
observed in most of the 50 participating countries including in Asia, Europe and North 
America. However, a decreasing trend was found in Central America with annual rate 
of decrease of 3.6%.   
 
The SEARCH for Diabetes in Youth study conducted in the USA assessed T1DM risk 
in terms of ethnicity, sex, and age
51, 55
. A total of 1905 individuals below the age of 20 
years old with T1DM were identified. The prevalence of T1DM was about 2.28/1000 
in this age group. T1DM accounted for almost all cases of diabetes in the group 
younger than 10 years of age. T1DM incidence rates for non-Hispanic white children 
were higher than for those of any other ethnic background. The incidence rate increased 
with age from 0 to 14 years, from about 14.3 to 25.9/100,000 person-years, but 
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decreased thereafter. An increasing temporal trend was also observed in the SEARCH 
study. 
 
In Europe, 44 centers participated the EURODIAB ACE study from 1989 to 1994
56, 57
. 
A total of 16,362 incidences of T1DM were identified. The T1DM risk varied 
significantly among regions. Macedonia had an incidence rate as low as 3.2 compared 
with 40.2/100,000 person-years in some parts of Finland. The average increase in rate 
was about 3.4% although it varied between countries. 
 
2.3.2 Risk factors 
T1DM has been associated with genetic factors, even though most cases do not have a 
family history of the disease. In one study after a long period of follow-up, 
monozygotic twins showed a concordance rate of 60% and dizygotic twins had a rate of 
6–10%58, 59. The genetic effect is strongest in early childhood-onset disease and modest 
in T1DM with onset in adulthood
60, 61
. Onset before 5 years of age is a strong indicator 
of a high family risk and genetic disposition
62
. It was shown that, by the age of 20, the 
risk for siblings of children with T1DM onset before 5 years of age was increased 5-
fold compared to siblings of those with disease onset between 5 and 15 years
62
. 
 
Human leukocyte antigen (HLA) complex on chromosome 6, particularly HLA class II, 
plays the most important role among many other genes involved in susceptibility to 
T1DM. Two haplotypes in the HLA class II region are considered to be the principle 
susceptibility markers for T1DM
63
. Around 90% of children with T1DM carry at least 
one of these markers
64
. Many other diverse genes are also important for genetic 
susceptibility. For example, the association between T1DM and autoimmune diseases, 
including autoimmune thyroid disease, Addison’s disease, celiac disease, and 
autoimmune gastritis, has been well established
65
. These disorders are all related to 
genes within the major histocompatibility complex
66
.  
 
Ethnicity is associated with risk of T1DM. In a migration study conducted in the USA 
among subjects less than 20 years old, the T1DM incidence rate varied by age and for 
different ethnic groups: non-Hispanic white, 11.9 to 32.9/100,000; African-American, 
9.5 to 21.3/100,000; Hispanic, 8.7 to 18.4/100,000; Asian and Pacific Islanders, 5.2 to 
9.1/100,000; and Navajo, 1.15 to 4.03/100,000 person-years. It was concluded from the 
study that the incidence rate of T1DM for non-Hispanic white youth is among the 
highest in the world
67-71
. Prevalence of risk factors for diabetic complications, such as 
increased low-density lipoprotein, overweight, and smoking, was also found to differ 
across ethnicity groups. 
 
Age, sex, and seasonality are also associated with T1DM. More than 85% of diabetes 
cases among individuals below 20 years of age are T1DM
51, 72, 73
. Most studies showed 
that the risk of T1DM increased from birth and reached a peak at around the age of 10 
to 14, and thereafter the risk seemed to stabilize in age 15 to 29 years
54-56
. The 
incidence rate of T1DM for adults was lower than for children
74
. Among populations 
with high risk of T1DM, there were more male than female cases and, by contrast, , 
there were more female than male cases among low-risk populations
75, 76
. Season of 
diagnosis and season of birth have been shown to be associated with risk of T1DM. 
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Among children and adolescents, the incidence diagnosed is highest during late 
autumn, winter, and early spring
77
. The seasonal variation in infections has been 
suggested to play a major role in this seasonal pattern of T1DM incidence, although 
evidence regarding specific infections is inconclusive
78, 79
. Children born in spring had 
a higher risk of T1DM compared with those born in autumn
80
. This pattern has been 
confirmed in the USA, parts of Europe, New Zealand, and Israel
81-86
. In the US 
SEARCH study, the effect of season of birth was observed in the most northern 
latitudes
80
. A possible explanation for this is that seasonal variation in vitamin D level 
might affect both beta cells and immune cells. Lack of sunshine reduces the level of 
vitamin D, and vitamin D deficiency is associated with an increased risk of T1DM
87, 88
. 
 
2.4 THE HEALTHCARE SYSTEM IN SWEDEN 
Sweden is a county with high-quality healthcare and the principle of offering a 
standardized quality of care to all legal residents at low cost. Healthcare is mainly 
delivered by hospitals, and primary care is provided in health centers. In addition to 
county hospitals, there are tertiary university hospitals in all six healthcare regions 
which provide highly specialized medical services. Based on the 1982 Health Care Act, 
a strong commitment to equality of access to healthcare has been established. 
According to a report from the Social and Cultural Planning Office in the Netherlands 
in 2004, the healthcare system in Sweden was one of the best, in terms of waiting time 
for non-acute care, public confidence in health services, and health status of the general 
population, among countries including Australia, Canada, New Zealand, the USA, and 
25 European Union member states
89
.  
 
2.5 RATIONALE FOR STUDIES INCLUDED IN THIS THESIS 
Some Swedish studies examined the association between MI incidence and sex, age, 
country of birth, and socioeconomic position (SEP). During the period 1987 to 1995, a 
total of 368,905 incidences of MI among 345,254 individuals were identified in 
Sweden.
90
 The incidence rate was lower in women in all age groups, and increased 
steeply with age for both women and men.  A case–control study conducted in 
Stockholm County from 1977 to 1996 found that overall both for men and women 
foreign-born individuals had a higher incidence of MI compared with those born in 
Sweden after adjusting for SEP, even though the incidence rate of MI for foreign-born 
individuals followed a decreasing trend in the general Swedish population
91
. Another 
study based on data from Stockholm County showed that the incidence rate ratio (IRR) 
in low-income compared to high-income neighborhoods was increased 1.88-fold and 
1.52-fold in women and men, respectively
92
.  
         
MI mortality has also been investigated in terms of sex, age, country of birth, and SEP 
in Sweden. During the period 1987–1995, the overall crude 28-day case fatality among 
patients 30–89 years old with acute MI in Sweden was 42% in men and 45% in 
women
93
. Hospitalized women had a slightly higher 28-day MI fatality rate than men. 
Over 50% of deaths within 28 days occurred outside hospital. One study showed, that 
men had higher pre-hospital mortality than women, except among individuals younger 
than 50 years
94
. These findings were basically consistent with those of other 
international studies
95-97
. During the period 1987 to 1995, both the 28-day and 1-year 
MI case fatality rates improved in all age groups in Sweden
93
. A study conducted in 
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Stockholm showed that male immigrants had a lower adjusted 28-day mortality after 
the fMI compared to Sweden-born individuals
90
. There was no significant difference in 
1-year survival after adjusting for SEP among foreign-born and Sweden-born 
patients
90
.  A study conducted in Malmo showed that men aged below 75 years from 
low SEP residential areas tended to have a higher 28-day MI case fatality rate 
compared with men from median and high SEP areas
98
. The decreasing trend in MI 
case fatality rate was only found in MI patients from median and high but not low SEP 
residential areas
98
.  
 
Previous Swedish studies of access to cardiac care and treatments largely investigated 
the impact of sex, age, and SEP, but not country of birth. A Swedish study in the city of 
Gothenburg showed that only 60% of hospitalized MI patients were treated in a CCU
99
. 
Those MI patients without access to a CCU were mostly women, and were on average 
10 years older and had more comorbidities than patients treated within CCUs. Another 
Swedish study of patients treated for coronary heart disease from 1991 to 2000 showed 
that men were 1.5 times more likely to undergo revascularization procedures than 
women after adjusting for confounding factors
100
. High-grade non-manual male 
workers were more likely to receive CABG compared to unskilled male manual 
workers; however, the IRR decreased from 1.4 to 1.0 during the study period
100
. 
Another Swedish study showed that, between 1993 and 1996, MI patients with the 
highest cumulative income were two or three times more likely to receive 
revascularization procedures within 1 month than those with low cumulative income
101
. 
The effect of country of birth has not been investigated in Sweden, even though racial 
differences in care after acute MI have been widely reported internationally
102-105
.  
 
T1DM is a major public health issue and burden for young patients as well as for 
society
106
. Related studies showed a wide variation in the incidence of T1DM both 
between and within countries
53, 56
, and between socioeconomic
107
 and ethnic groups
108
. 
In Sweden, one study showed an increasing T1DM trend among children
109
. The 
increase in the number of T1DM patients and an increased need for high-quality 
disease management create a huge burden for patients and society
110
.  
 
It has been suggested that migration studies can provide a way to assess the influence 
of the interaction of genes and environment on this disorder
111
. If the children of 
immigrant families have a risk of disease between that of their parents and the general 
population of the country from which they immigrated to Sweden, it is likely that 
environmental factors play a role. Although there is evidence for an increasing 
incidence of T1DM at younger ages, it is still unclear whether this increase is relevant 
to all population groups with diverse ethnic backgrounds. Moreover, the findings from 
studies investigating SEP and risk of T1DM have been inclusive
112-115
.  
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3 AIMS OF THIS THESIS 
 
3.1 GENERAL AIM 
 
The aim of this thesis was to examine the effect of country of birth, SEP, sex, and age 
on the risks and time trends of fMI and T1DM, and on the equity of admission to 
specialized care and access to evidence-based treatments after fMI.  
 
3.2 SPECIFIC AIMS 
 
The specific aims of the studies described in this thesis were: 
 
 To assess whether the incidence and time trends of fMI vary by country of 
birth, sex, and SEP (Paper I); 
 To assess whether case fatality after 28 days of diagnosis of fMI varies by 
country of birth, sex, and SEP (Paper I); 
 To assess the differences in admission to a CCU after fMI between immigrants 
and Sweden-born patients (Paper II); 
 To assess the differences in admission to a CCU after fMI between men and 
women (Paper II); 
 To assess the differences in admission to a CCU after fMI among patients of 
different SEP (Paper II); 
 To determine the equity of access to coronary angiography in CCUs after fMI 
between immigrants and Sweden-born patients (Paper III); 
 To determine the equity of access to PCI in CCUs after fMI between 
immigrants and Sweden-born patients (Paper III); 
 To determine the equity of access to CABG in CCUs after fMI between 
immigrants and Sweden-born patients (Paper III); 
 To assess whether the incidence and time trends of T1DM vary by country of 
birth, sex, and SEP (Paper IV). 
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4 MATERIALS AND METHODS 
 
4.1 MATERIALS 
The data used for the four studies in this thesis were from the M&H Co. This cohort 
was built by linkage between a large number of Swedish national health and 
demographic registers to study cancer and cardiovascular and psychiatric diseases 
among immigrants and their descendants compared with Sweden-born residents. The 
linkage has been completed through the 10-digit PIN by Statistics Sweden and The 
Swedish National Board of Health and Welfare.  The PIN has been removed and 
replaced by an identification number and the key is kept by these authorities.  
 
The data in the M&H Co were obtained from the following registers.  
 
4.1.1 The Total Population Register 
The Total Population Register is the basic register of the Swedish population. Most 
individuals who were born in Sweden and those who migrate to Sweden are registered. 
Individuals remain in the register until the date they move abroad or die. It contains 
information on: 
• Name 
• Address 
• PIN 
• Place of birth, in Sweden or abroad 
• Citizenship 
• Civil status 
• Spouse, children, parents, guardian(s), and adoption 
• Property, parish, and municipality of registration 
• Immigration to and emigration from Sweden 
• Address abroad 
• Death and place of burial 
 
Registration of population data in Sweden has a long history. It can be dated back to the 
17
th
 century and was started by the Church
116
. The Total Population Register was 
established in 1968 through merging of registers at the country administrative boards. 
The PIN was also introduced in Sweden when the population registration was 
computerized. All those registered have a permanent life-long PIN
116
. The PIN shows a 
person’s date of birth (first six digits) and sex (the second last number is odd for men 
and even for women). 
 
The Swedish Tax Agency is responsible for the Total Population Register, and updates 
information from other public agencies. Registered residents are required to submit 
information about themselves including change of address, immigration and 
emigration, names of newborn children, and certain name changes. 
 
Although the Total Population Register is supposed to cover registration of the entire 
population in Sweden, both undercoverage and overcoverage are possible. At present, 
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an exact estimation of these errors is not available
10, 117
. Undercoverage, where 
individuals who should be registered in fact are not, can occur due to late reporting of 
birth or immigration. It was estimated that the median waiting time for an immigrant to 
be registered in the Total Population Register was about 21 weeks in 1996
10
.  Over 
coverage, where individuals who should be removed from the register in fact are not, 
can occur due to late reporting of death or emigration. It is likely that those who no 
longer live in Sweden are still registered because emigration is self-reported. It was 
estimated that overcoverage among non-Nordic foreign-born persons can be high as 4–
8%
10, 117
. 
 
4.1.2 The Patient Register 
From 1965, the National Board of Health and Welfare in Sweden began collecting data 
on individual hospital discharges in the Patient Register
118
. At discharge from hospital, 
a specific form is completed for each patient without exception. First these forms are 
computerized locally, and then the data are stored in administrative registers held at the 
hospitals and the county administrative offices. The data are delivered once a year to 
the National Board of Health and Welfare. Each record represents one in-hospital 
episode. In addition to the PIN, administrative information such as admission and 
discharge dates, hospital and department codes, and up to eight discharge diagnoses are 
recorded. Diagnoses in the Patient Register are coded according to the Swedish 
International Classification of Diseases (ICD) system, first introduced in 1964 (adapted 
from the WHO ICD system)
119
. The ICD 10th revision (ICD-10) was introduced in 
1997. The register has had nationwide coverage since 1987
118
. Since 2001, this register 
has also contained information on outpatient visits to specialist care and day visits to 
hospital
120
. 
 
Each year, the Patient Register includes approximately 1.7 million records of hospital 
care
118
. The number of patients included in the register in 2008 was about 800,000
121
. 
Currently, more than 99% of all somatic (including surgery) and psychiatric hospital 
discharges are recorded in the Patient Register
119
. It has been estimated that the PIN is 
missing in about 1% of cases and the principle diagnosis is also missing for a further 
1%
121
. The positive predict value of diagnosis in the register was found to be about 
85% to 95% and it was concluded that this is a very valuable data source for large-scale 
register-based research
119
. It was also shown that the quality of MI diagnosis in the 
register was good, and suitable for epidemiological studies
122
.  
 
4.1.3 The Cause of Death Register 
The Cause of Death Register provides a basis for official statistics on cause of death in 
Sweden
123
. It is administered by the Swedish Board of Health and Welfare. It covers all 
deceased persons who at the time of death were registered in Sweden, whether the 
death occurred within or outside the country. It does not include stillbirths, or deaths of 
those who died during a temporary stay in Sweden, of asylum seekers who have not yet 
received a residence permit, or of those who have emigrated and are no longer 
registered in Sweden.  
 
The register contains data from 1961 and is updated annually. Diagnoses in the Cause 
of Death Register are coded according to the WHO version of the ICD. It contains an 
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individual’s PIN and information on place of residence, underlying cause of death, 
contributing causes of death, nature of any injury, date of death, sex, marital status, age, 
whether or not an autopsy was carried out and if so type of autopsy, death abroad, 
surgery within 4 weeks before death, and intent in cases of injury or poisoning. 
 
The cause of death was estimated to be missing in a maximum of 0.5% of all deaths 
and there has been no loss since 1997
10
. The change in ICD system might also 
influence the time trend. New legislation that allows families greater opportunity to 
decline an autopsy and the changing regulations for forensic death investigation have 
led to a decrease in the number of autopsies. The proportion of autopsies has decreased 
from around 50% in the early 1970s to about 12% in 2007
124
. It has been shown that 
the register is reasonably valid for use in epidemiological studies and mortality 
statistics with regard to diseases, including ischemic heart disease
125
. 
 
4.1.4 The Swedish Population and Housing Census (FoB)  
Since 1960, an FoB was conducted every 5 years until 1990. The information in the 
FoB was obtained partly from the questionnaire sent to the public and partly from 
available records. 
 
The FoB collected data on individuals and households. The content of different FoBs 
varied to some extent but all included demographic data on individuals, education level, 
employment status and occupation. Income data are available in several FoBs. 
Household data included number of residents, household status, and overcrowding. 
Data on ownership, the year dwelling built, tenure, and number of rooms were also 
collected.  
  
4.1.5 Longitudinal integration database for health insurance and labor 
market studies (LISA) 
The database presently holds annual registers since 1990 and includes all individuals 16 
years of age and above who were registered in Sweden as of December 31 for each 
year. The database incorporates existing data from the labor market and from 
educational and social sectors and is updated each year with a new annual register. The 
individual person is the main concern of LISA, but links to family and place(s) of 
employment are also available.  
 
The database provides a basis for longitudinal statistics and research into entire 
populations/groups or geographic areas, as well as education, employment, and 
alternatives (studies, parental leave, unemployment, etc.). 
 
The individual section of the database includes information on the following: 
employment; income or compensations from employment, entrepreneurial activities, 
studies, national military service, illness, parental leave, unemployment, labor market 
activity, rehabilitation, partial retirement, early retirement, retirement, occupational 
pension, annuities, social assistance, private pensions, etc.; disposable income; country 
of birth and parental country of birth; latest year of immigration; place of residence 
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(county, municipality, parish, and property); place of employment (county and 
municipality); and highest level of education. 
 
4.1.6 Register of Information and Knowledge about Swedish Heart 
Intensive Care Admissions (RIKS-HIA)  
The objectives of RIKS-HIA are to support evidence-based development of treatments 
for acute CAD. It provides continuous information on care needs, treatments, treatment 
outcomes, and prognosis during hospitalization.  
 
RIKS-HIA was established at the beginning of the 1990s as a regional registry. Since 
1995, it has become a national quality register. Registration in RIKS-HIA now includes 
all admissions for cardiac intensive care in almost every hospital in Sweden. In 2004, 
72 hospitals participated in RIKS-HIA and 62,020 hospital admissions were registered, 
of which 19,516 were due to acute MI. RIKS-HIA is well distributed throughout 
Sweden covering both urban and sparsely populated areas (Figure 4.1.6). RIKS-HIA is 
an internationally unique system with relatively complete coverage of all admissions 
for cardiac intensive care with suspicion of acute MI in the whole of Sweden
126
. 
 
Internal and external validation of the recorded data in the registry is continuously 
conducted. The internet-based data entry system has access to interactive instructions, 
manuals, definitions, and help functions. The local responsible person performs regular 
controls of completeness of data entry regarding variables and patients. The register is 
also monitored through visits to the participating centers for source data verification. 
The monitoring process is conducted every year in hospitals and around 30 randomly 
sampled patients are compared with local patient records in each hospital. It was shown 
that on average 94% of variables are correctly entered into the register
126
. 
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Figure 4.1.6: Hospitals participating in Register of Information and Knowledge about 
Swedish Heart Intensive care Admissions (RIKS-HIA) in Sweden in 2004 (Source: 
RISK-HIA report, 2005) 
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4.1.7 Swedish Coronary Angiography and Angioplasty Registry 
(SCAAR) 
The total number of patients who undergo coronary angiography or PCI has 
continuously increased in Sweden as well as internationally. SCAAR is a procedure-
related register that contains all relevant information about interventions and 
procedures performed. It was created in 1991 to register PCI procedures performed in 
Sweden. In 1992, a coronary angiography register, Acta Coronaria, was set up to record 
coronary angiographies performed in Sweden. During 1992 to 1998, 60,000 procedures 
were registered
127
. At the end of 1998, these two registers were merged as a single 
register, SCAAR.  
 
Coronary angiography is performed at 30 hospitals of which 28 also perform PCI
128, 129
. 
In 2005, all coronary angiography and PCI procedures were included in SCAAR except 
for those performed at Skövde Hospital
130
. At the end of 2005, SCAAR recorded 
information from 201,000 coronary angiography and 116,000 PCI procedures
130
. 
Information collected included demographic data, risk factors, intervention, puncture 
site, angiography findings, primary treatment decision after angiography, 
complications, and clinician who performed the procedure. Stenosis characteristics and 
type of stent were registered for PCI. Procedure-related data included transillumination 
time and number and type of X-ray contrast agents, and antithrombotic treatment 
during the procedure was also recorded
128
.  
 
From 2001 onwards, all data have been reported to SCAAR online. The database is 
located at Uppsala Clinical Research Center (UCR) in Sweden. It is updated daily and 
all reporting teams have access to analyses and reports. Quality control and monitoring 
of registry data take place in 28 hospitals performing PCI. About 20 randomly selected 
interventions per hospital are reviewed. Quality control is performed to assess the 
reliability and improve the quality of input data. Connecting SCAAR with other 
registers enables long-term follow-up of procedure outcomes, such as mortality, 
relapse, and other complications
128
. 
 
4.1.8 Swedish Heart Surgery Registry 
The Swedish Heart Surgery Register was established in 1992. It has recorded all heart 
operations performed on children and adults in Sweden since its establishment. 
Approximately 8000 heart interventions are performed annually. Around 130,000 
surgeries had been registered up to 2007.  
 
The register contains patients’ demographic information such as age, sex, PIN, and 
county of residence. Other key variables include waiting time for the procedure, length 
of hospital stay, type of procedure, presence of diabetes, and certain complications after 
surgery such as infection, renal failure, stroke, and the need for mechanical circulatory 
assistance
131
.   
 
The participating clinics report four times a year to UCR. UCR reviews the data and 
provides feedback to the clinics if further clarification or information is needed. All 
clinics have direct access to their own data for analysis. Apart from annual reports 
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produced by UCR, the information is also used by healthcare professionals at meetings, 
symposia, and conferences. The register reports provide transparent information on 
surgical outcomes at the clinical level for comparison of data between clinics
131
.  
 
4.2 STUDY POPULATIONS AND DESIGNS 
4.2.1 Paper I 
In this nationwide population-based cohort study, we used the M&H Co to study trends 
in fMI incidence and case fatality after day 28 and to examine the role of sex, education 
as an indicator for SEP, and birth country on these events in Sweden. Between January 
1, 1987 and December 31, 2008, 3,426,243 men and 3,326,412 women, aged 35 to 89 
years living in Sweden at any time during the study period were included in the study 
of fMI incidence.  Case fatality after day 28 was then studied among the 224,498 male 
and 141,587 female initially non-fatal cases. 
 
4.2.1.1 Exposure variables 
1) The main exposure variable was country of birth. We first used the term 
‘foreign-born’ individuals as an indicator of immigrants and ‘Sweden-born’ 
individuals as an indicator of Swedish persons. By definition, a foreign-born 
person was born in another country outside of Sweden no matter where his/her 
parents were born; a Sweden-born person was born in Sweden irrespective of 
his/her parents’ countries of origin. Information regarding country of birth was 
obtained from the Swedish Total Population Register.  
 
We classified foreign-born individuals into six main geographical regions, 
Africa, Asia, Europe, Latin-America, Northern America, and Oceania, and into 
nineteen geographical subregions according to the United Nations 
classification
132
. At the country level, we reported only countries with five or 
more MI cases. 
 
Other migration health studies have used the variable ethnicity instead of 
country of birth. We considered that ethnicity is a complex subjective and 
objective classification. Many countries consist of numerous ethnic groups and 
one ethnic group can be presented in many countries. The ever increasing rate 
of interracial marriage also complicates the classification of ethnicity
133
. Thus, 
the definition of country of birth in this thesis is clearly different from that of 
ethnicity although both are used in migration health studies. We were aware of 
the potential limitation of use of country of birth in our study to distinguish 
Swedish and non-Swedish person. It is possible that an individual was born 
overseas with parents who were both born in Sweden. It is also likely that a 
Sweden-born person may have at least one parent who was born overseas.  
  
2) Other exposure variables evaluated in the study include SEP and sex. We used 
highest education level as an indicator of SEP, which is a subjective variable. 
We believe that health awareness is more strongly associated with health 
behavior in a person’s daily life than other factors such as income. In particular, 
Sweden offers equal access to health services at minimum cost. Secondly, 
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education is a table factor during the study follow-up. By contrast, we 
considered that other indicators such as income and occupation were much less 
stable. Income might change during the study period because of inflation, 
marriage, divorce, loss of job, or other significant life events. It is also difficult 
to classify occupation because participants are very likely to change their jobs 
during the study follow-up.   Moreover, some studies showed that education 
level was a reasonable surrogate for SEP
134
. We divided levels of education into 
four categories: 0–9 years, 10–12 years, more than 12 years, and unknown. We 
retrieved information regarding the highest education level from FoB and LISA. 
Individuals were classified as men and women, using information obtained 
from the Total Population Register. 
 
4.2.1.2 Follow-up and outcome variables 
1) Follow-up was from January 1, 1987, first immigration date for foreign-born 
individuals, or 35
th
 birthday, whichever occurred last, until the date of diagnosis 
of an acute MI (ICD 9th revision (ICD-9) code 410 and ICD-10 code I21), first 
emigration, death, 90
th
 birthday, or end of follow-up (December 31, 2008), 
whichever occurred first. Only diagnoses of fMI were counted as an event. 
Patients with recurrent MI during the 21 years of follow-up were only counted 
once. Specific diagnosis information was obtained from both the National 
Patient Register and the Cause of Death Register.  
 
2) Non-fatal incident cases of fMI were followed from the date of diagnosis until 
the date of death due to MI either as underlying or contributory cause, death due 
to other causes, first emigration date, 90
th
 birthday, or end of follow-up 
(December 31, 2008), whichever occurred first. We investigated first death due 
to MI as an underlying or contributory diagnosis (ICD-9: 410; ICD-10: I21), 
repeated analysis for coronary heart disease (ICD-9: 410–414; ICD-10: I20–
I25), and death due to any causes as an event. The cause of death and date of 
death were obtained from the Cause of Death Register.  
 
4.2.1.3 Other explanatory variables 
Age was arbitrarily divided into eleven groups in 5-year intervals (35–39, 40–44… 80–
84, and 85–89). In 2000, WHO criteria for MI were refined to further emphasize the 
importance of cardiac biomarkers for diagnosis
12
.  The adaptation of these new criteria 
might have affected the incidence of MI
135
. Therefore, we divided the total study period 
into four time periods: 1987–1990, 1991–1995, 1996–2000, and 2001–2008. 
Additionally, comorbidity status, including history of diabetes, hypertension, and 
hyperlipidemia recorded in the Patient Register any time during the study period of 
1987–2008, was considered in the analysis (yes/no).  
 
4.2.2 Paper II 
In this nationwide cohort study, we examined admission to CCUs in association with 
country of birth, SEP, and sex after patient diagnosed with fMI (ICD-10: I21). We 
identified fMI patient who were admitted to hospital and registered in the National 
Patient Register between 2001 and 2009. Then whether they were admitted to CCU 
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during the same hospitalization was checked in RIKS-HIA. The study period was 
limited from 2001 was because RIKS-HIA had better nationwide coverage after that. 
The study population thus comprised 114,387 men (13,903 foreign born) and 85,519 
women (9,601 foreign born).   
 
4.2.2.1 Exposure variables 
We studied the same exposure variables as in the first study (Paper 1): country of birth, 
SEP, and sex. Furthermore, classification of the exposure variables was exactly the 
same as in study 1.  
 
We defined the country of birth into two major groups: foreign-born and Sweden-born 
individuals. We classified foreign-born individuals into six main geographical regions: 
Africa, Asia, Europe, Latin-America, Northern America, and Oceania, and into 
nineteen geographical sub-regions according to United Nations classification
71
. At the 
country level, we reported only data from countries with five or more cases. We used 
highest education level as an indicator of SEP. The levels of education were classified 
into four categories: 0–9 years, 10–12 years, more than 12 years, and unknown. The 
study individuals were classified as men and women, using information obtained from 
the Total Population Register. 
 
4.2.2.2 Outcome variable 
Admission to CCU (yes/no) was the study outcome variable. We retrieved this 
information from RIKS-HIA. If a patient was admitted to the CCU more than once 
during the same period of hospitalization, this was treated as one CCU event. 
 
4.2.2.3 Other explanatory variables 
Age at diagnosis of fMI was arbitrarily categorized into 13 strata each of 5 years (less 
than 35, 35–39, 40–44… 85–89, and 90 and above) due to a non-linear relationship 
with the outcome. We divided the total study period into three arbitrary time periods: 
2001–2003, 2004–2006, and 2007–2009. Additional co-variables considered in the 
analysis were medical conditions including diabetes (ICD-9: 250; ICD-10: E10–E14), 
hypertension (ICD-9: 401; ICD-10: I10), and hyperlipidemia (ICD-9: 272; ICD-10: 
E78), as well as a history of stroke (ICD-9: 430–438; ICD-10: I60–I90), heart failure 
(ICD-9: 428; ICD-10: I50), angina (ICD-9: 413; ICD-10: I20), atrial fibrillation (ICD-
9: 427D; ICD-10: I48), pulmonary embolism (ICD-9: 415B; ICD-10: I26), chronic 
obstructive lung disease (ICD-9: 490–496; ICD-10: J44), and cancer (ICD-9: 140–239; 
ICD-10: C00–D48). All medical conditions were verified for a fixed period of 14 years. 
Moreover, to exclude variation between hospitals in the availability of CCUs that might 
have an impact on the possibility of admission, we classified hospitals into two 
categories: with and without CCU facilities (yes/no).  
 
4.2.3 Paper III 
In this nationwide cohort study, we examined the relationship between country of birth 
and the utilization of coronary angiography, PCI, and CABG after an fMI. A total of 
117,494 fMI patients of all ages who were admitted to CCUs between 2001 and 2009 
in Sweden were followed for 3 months after CCU admission. 
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4.2.3.1 Exposure variable 
The exposure variable in the third study was country of birth. Country of birth was 
classified as in studies 1 and 2. We defined the country of birth into two major groups 
foreign-born and Sweden-born. We classified foreign-born individuals into six main 
geographical regions: Africa, Asia, Europe, Latin-America, Northern America, and 
Oceania, and into nineteen geographical sub-regions according to United Nations world 
classification
71
. At the country level, we only reported data from countries with five or 
more cases. 
 
4.2.3.2 Follow-up and outcome variables 
Patients were followed from the date of admission to CCU until either the date of 
undergoing the treatments or censoring within 3 months. Censoring occurred if a 
patient was lost to follow-up due to death, emigration, or the end of the 3 months of 
follow-up. Within the follow-up period, a record of angiography, PCI, or CABG was 
considered as an event separately. Only the first event was considered in this study. 
 
Information regarding angiography, PCI, and CABG was obtained from RIKS-HIA, 
SCAAR, and the Swedish Heart Surgery Registry. 
 
4.2.3.3 Other explanatory variables 
Potential confounders adjusted for in the model included the demographic factors sex, 
age at diagnosis, and year of diagnosis. The continuous variable age at diagnosis of fMI 
was classified into 13 strata (less than 35, 35–39, 40–44… 85–89, and 90 and above) 
due to a non-linear relationship with the outcome variables. We divided the total study 
period into three arbitrary time periods: 2001–2003, 2004–2006, and 2007–2009. 
 
Medical information was classified into admission information, clinical information 
during hospitalization, and complications during treatment. Admission information 
included use of angiotensin-converting enzyme inhibitors at admission, whether or not 
admitted by ambulance, beta-blockers prior to admission, cardiac shock at admission, 
ECG QRS complex, ECG rhythm, ECG ST and T (STT) wave changes, type of MI, 
previous PCI, presenting symptoms,  prior cardiac surgery, pulmonary rates, smoking 
status, and use of statins before hospitalization. Clinical information during 
hospitalization included beta-blocker use during treatment, diuretic treatment, and 
anticoagulant therapy. Complications included atrioventricular block (AV block), 
myocardial re-infarction during hospitalization, and new fibrillation/flutter during 
hospitalization. Risk factors included diabetes and hypertension. The medical 
information was obtained from RIKS-HIA. 
 
The highest level of education achieved was used as a proxy for SEP. Education level 
was divided into four categories: low (0–9 years), medium (10–12) years, high (more 
than 12 years), and unknown. 
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4.2.4 Paper IV 
In this nationwide population-based cohort study, we investigated associations between 
country of birth, parental country of birth, and education with respect to risk and time 
trends of T1DM among children and young adults. We followed a nationwide cohort of 
4,469,671 male and 4,231,680 female subjects aged 0–30 years between 1969 and 
2008.  
 
4.2.4.1 Exposure variables 
1) We studied the effect of country of birth. However, in contrast to the above-
mentioned three studies, we defined country of birth in three major groups: 
individuals born outside Sweden, referred to as immigrants; those born in 
Sweden with at least one parent born outside Sweden, referred to as offspring of 
immigrants; and those born in Sweden with both parents born within the 
country, referred to as Sweden-born individuals. 
 
We classified foreign-born individuals into six main geographical regions and 
further into 19 world regions defined by the United Nations Population 
Division, as in studies 1 and 2: Africa (North, South, East, West, and Central 
Africa), Asia (East, West, South-Central, and South-East Asia), Europe (North, 
South, East, and West Europe), Latin America (Caribbean, Central America and 
South America) Northern America, and Oceania (Australia/New Zealand, 
Melanesia, and Micronesia/Polynesia). At the country level, we only reported 
results from countries having at least five cases of T1DM; data from those with 
fewer than five cases were combined and are presented as ‘other‘ for each 
geographical region. 
 
2) We classified individuals by their parental level of education as an indicator of 
SEP. Education was categorized into four levels: 0–9 years, 10–12 years, 13 
years or more, and unknown. We used the highest parental education level in 
the family, i.e. the mother´s education category was used if she had a higher 
level than the father. 
 
4.2.4.2 Follow-up and outcome variable 
Individuals were followed from 1969, their date of birth, or date of immigration for the 
immigrants, whichever occurred later, until the date of diagnosis of T1DM (code 250 
according to ICD 8th revision and ICD-9 between 1969 and 1996, and ICD-10 code 
E10 from 1997), emigration, death, or end of follow-up in 2008, whichever occurred 
earlier. The diagnosis of T1DM was obtained from the National Patient Register. 
Information regarding emigration, immigration, and date of birth was obtained from the 
Total Population Register, and information regarding death from the Cause of Death 
Register.  
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4.2.4.3 Other explanatory variables 
Age at follow-up was divided into six groups in 5-year intervals (0–4, 5–9, 10–14, 
15–19, 20–24, and 25–30 years). The study was divided into four time periods (1969–
1979, 1980–1989, 1990–1999, and 2000–2008). 
 
4.3 STATISTICAL ANALYSIS 
 
4.3.1 Poisson regression 
We used Poisson regression to calculate IRRs with 95% confidence interval (CI) of fMI 
and T1DM (Papers I and IV).  
 
Poisson regression is often used to model counted data or contingency tables. Poisson 
models are a form of generalized linear models which use natural logarithm as the link 
function. Poisson regression assumes that the outcome variable Y has a Poisson 
distribution. Poisson distribution describes the probability of a given number of events 
occurring in a fixed interval of time or space if the events are independent of time since 
previous events and occurred at an average rate. It can be used in other contexts, such 
as distance and volume. We assumed that the fMI and T1DM events that occurred in a 
fixed time interval had Poisson distributions
136, 137
. 
 
A feature of Poisson distribution is that it assumes the mean of the event number is 
equal to its variance. In many circumstances, the observed variance is greater than its 
mean. This is known as over-dispersion. In this case, the standard error of the 
coefficients might have to be re-estimated, as in the studies included in this thesis. 
Alternatively other models have been suggested, such as negative binomial 
regression
138
.  
 
4.3.2 Cox proportional hazard regression 
We used Cox proportional hazard regression to model fMI case fatality and likelihood 
of undergoing cardiac procedures. Hazard ratio (HR) with 95% CI was used to compare 
different groups (Papers I and III). 
 
Cox proportional hazard regression has been widely used in the analyses of time to 
event data with censoring and covariates. It is similar to Poisson regression in that both 
methods estimate rate ratios. However, it does not assume the nature or shape of the 
hazard function; instead it assumes that hazard rate is proportional throughout the 
follow-up period.  
 
4.3.3 Logistic regression 
Logistic regression is a form of regression that is applied when the dependent variable 
is dichotomous. We modeled admission to the CCU (yes/no) using logistic regression. 
The odds ratio (OR) was calculated to compare the likelihood of admission to the CCU 
among different comparison groups (Paper II). 
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The logistic regression model is an extension of classical linear models to address non-
normal outcomes. In classical linear models, it is assumed that the outcome is 
independent and normally distributed with equal variance. However, it is not valid for a 
dichotomous outcome, such as admission or not admission to the CCU. In logistic 
regression, the outcome is the Logit transformation of the binary variable. It assumes 
that the transformation of the binary outcome variable is independent and normally 
distributed with equal variance. Logistic regression is one of the most successful 
applications of likelihood-based modeling
139
.   
 
4.3.4 Joinpoint regression 
The Joinpoint regression model was used (Papers I and IV) to analyze the time trends 
in fMI and T1DM.  
 
Joinpoint regression fits a series of joined straight lines on a log scale to the incidence 
rate data. Line segments are joined at positions termed joinpoints. Each jointpoint is 
tested if it shows a significant change in overall trend. The method also estimates the 
annual percent change (APC) to describe the trend and to test whether it is statistically 
significant. The null hypothesis in the test is that there is no trend in change in 
incidence rates
140, 141
.  
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Figure 6.1.1: Age-standardized first MI incidence rate by sex and immigration status, Sweden 1987-2008 
ASR=Age-standardized first MI incidence rate per 100,000 person-years 
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5 RESULTS 
5.1 RISK OF FMI AND CASE FATALITY AFTER DAY 28 (PAPER I) 
fMI incidence 
 
A total of 571,476 cases of fMI (344,349 men, 227,127 women) were observed during 
the study period between 1987 and 2008.  Of these fMI patients, 29,655 were foreign-
born men and 20,080 were foreign-born women. Foreign-born individuals were 
younger (mean age ± standard deviation (SD)) at diagnosis than their Sweden-born 
counterparts (men: foreign born 64.51 ± 12.01, Sweden born 70.77 ± 11.23 years; 
women: foreign born 72.12 ± 10.58, Sweden born 76.09 ± 9.83 years). 
 
 
 
Men had a higher age-standardized incidence rate (ASR) of fMI than women over the 
entire study period.  We observed a clear decrease in ASR of fMI over this period for 
men, but a less obvious decrease for women (Figure 6.1.1). When stratified by 
immigration status, there was a significant decreasing trend based on Jointpoint 
regression analyses during the whole study period which was more pronounced among 
Sweden-born (men APC, -2.1, p<0.0001; women: APC, -1.0, p<0.0001) than foreign-
born individuals (men: APC, -1.2, p<0.0001; women: APC, -0.4, p=0.05). 
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Figure 6.1.2: Age-standardized first MI incidence rate by education, Sweden 1987-2008 
ASR=Age-standardized first MI incidence rate per 100,000 person-years 
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The analysis of trend was also stratified by level of education. The results showed 
decreasing trends for men at all educational levels. For women, however, there was no 
obvious decrease especially for those with fewer than 12 years of education. The 
absolute risk difference between the highest and lowest educational level was higher 
among men than women. Most importantly, both men and women with low levels of 
education always had a higher ASR of MI than those with higher levels of education 
(Figure 6.1.2). 
 
Poisson regression was used to measure the IRR in relation to countries of birth, 
regions and continents. Compared with Sweden-born men, those from Southern and 
Western Asia showed high fMI risk patterns. By contrast, men from Eastern Asia, 
South-Eastern Asia, and Latin America showed low fMI risk patterns. Within Europe, 
there seemed to be a slight increasing risk trend from Southern and Western Europe to 
Northern and Eastern Europe (Table 6.1.1). Women showed similar risk patterns to 
men, but with fewer countries having a significant effect. Moreover, women from 
several African countries had a lower fMI risk than Sweden-born women. There were a 
few examples, notably Bosnia and Serbia in Europe, where countries within the same 
geographical region showed opposite fMI risk patterns. For specific IRRs relating to 
country of birth, please refer to Paper 1. 
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Table 6.1.1: Incidence rate ratio of first-time myocardial infarction in Sweden by birth 
region/country and sex, 1987–2008 
 Male Female 
Region of birth Cases PYRS$ IRR(95% CI) Cases PYRS$ IRR(95% CI) 
Sweden 314 694 42 853 105 1 207 047 46 751 289 1 
Africa 451 261 601 0.92 (0.84-1.01) 116 160 171 0.67 (0.56-0.80) 
   Northern Africa 205 92 646 0.97 (0.85-1.12) 32 39 072 0.62 (0.44-0.88) 
   Southern Africa 26 6 395 1.12 (0.76-1.64) 9   
   Western Africa 64 44 860 0.87 (0.68-1.11) 20 23 186 1.14 (0.73-1.76) 
   Eastern Africa 143 109 610 0.83 (0.71-0.98) 48 87 326 0.54 (0.40-0.71) 
   Middle Africa  13 80 90 1.07 (0.62-1.84) 7 5 245 1.26 (0.60-2.64) 
   Otherγ 34 29 219 0.76 (0.55-1.07) 16 33 872 0.59 (0.36-0.96) 
Asia 3 747 1 048 737 1.35 (1.31-1.40) 1 591 960 260 0.96 (0.91-1.01) 
   Eastern Asia 120 57 314 0.58 (0.48-0.69) 82 80 235 0.57 (0.46-0.71) 
   Southern Asia 1 258 364 795 1.47 (1.39-1.55) 481 290 986 0.98 (0.90-1.07) 
   South-Eastern Asia 127 67 814 0.74 (0.62-0.88) 81 164 440 0.55 (0.44-0.68) 
   Western Asia 2 242 558 814 1.47 (1.41-1.53) 947 424 600 1.09 (1.02-1.16) 
   Otherγ 36 15 013 1.15 (0.83-1.59) 40 53 891 0.74 (0.54-1.01) 
Europe 24 355 3 832 127 1.06 (1.05-1.07) 17 665 4 922 030 1.05 (1.04-1.07) 
   Nothern Europe 14 623 2 081 557 1.07 (1.05-1.08) 11 690 2 896 335 1.08 (1.06-1.11) 
   Southern Europe 3 861 839 397 1.11 (1.08-1.15) 1 756 753 749 1.04 (0.99-1.09) 
   Western Europe 2 600 416 736 0.93 (0.89-0.96) 1 860 489 334 0.89 (0.85-0.93) 
   Eastern Europe 3 271 494 437 1.10 (1.06-1.14) 2 359 782 612 1.06 (1.02-1.11) 
   Otherγ 8 3 029 0.91 (0.46-1.83) 9 11 345 0.59 (0.31-1.13) 
Latin America 446 229 134 0.74 (0.68-0.82) 242 256 521 0.58 (0.51-0.66) 
   South America 396 202 411 0.73 (0.66-0.81) 222 229 364 0.57 (0.50-0.65) 
   Central America 23 15 744 0.70 (0.47-1.06) 9 18 867 0.42 (0.220.82) 
   Caribbean 27 10 980 1.15 (0.79-1.67) - - - 
   Otherγ 28 14 423 0.83 (0.57-1.20) 14 34 476 0.42 (0.25-0.70) 
Northern America 619 947 54 0.97 (0.90-1.05) 435 94 772 0.94 (0.85-1.03) 
Oceania 14 10 681 0.92 (0.54-1.55) 9 7 500 1.19 (0.62-2.29) 
Study population: 35 to 89 years old with a valid Swedish ID. IRR was adjusted for age at follow-up, calendar period of follow-up, co-morbidity and 
education. IRR significantly different from 1 is highlighted. Statistically significant IRRs were highlighted. 
 
 
 
 
 
 
 
 
The incidence of fMI decreased with increasing level of education in both sexes (p for 
trend <0.0001).  Overall, the risk was higher among men and women with less than 9 
years of education compared with those with more than 12 years of education. This 
association was, however, stronger among women (men: IRR 1.66, 95% CI 1.64–1.68; 
women: IRR 1.99, 95% CI 1.95–2.03) (results not shown in the tables). Stratified 
analysis by immigration status yielded the same results in both sexes and among both 
Sweden-born and foreign-born patients. The increased risk remained stronger among 
women but was more pronounced in individuals born in Sweden than in immigrants 
(Table 6.1.2). 
 
 
 
 
 
 
 30 
 
 
 
 
 
Table 6.1.2: Incidence rate ratio for first-time myocardial infarction in Sweden by immigration 
status, sex, and level of education, 1987–2008  
 Sweden-born Foreign-born 
Cases PYRS
§ IRR* (95% CI) Cases PYRS§ IRR* (95% CI) 
       
Men       
Years of education       
   less than 9 164 877 15 270 026 1.60 (1.58-1.62) 11 820 1 579 919 1.49 (1.44-1.54) 
   9 to 12 85 221 16 970 986 1.36 (1.34-1.37) 10 557 2 198 635 1.29 (1.24-1.34) 
   more than 12 29 824 9 388 229 1 4 163 1 380 218 1 
    P for trend   <0.001   <0.001 
    unknown 34 772 1 223 863 1.41 (1.39-1.44) 3 115 327 946 1.18 (1.12-1.24) 
 
       
       
Wemen       
Years of education       
   less than 9 116 295 16 546 983 1.85 (1.81-1.89) 9 712 2 181 397 1.77 (1.67-1.87) 
   9 to 12 39 267 17 549 208 1.47 (1.44-1.50) 4 898 2 292 431 1.46 (1.37-1.55) 
   more than 12 10 391 10 532 509 1 1 334 1 465 487 1 
    P for trend   <0.001   <0.001 
    unknown 41 094 2 122 589 1.82 (1.77-1.86) 4 136 474 956 1.62 (1.52-1.73) 
§ 
person-years 
* Mutually adjusted for education, age, co-morbidities and calendar years of follow-up when 
applicable. 
Statistically significant IRRs were highlighted. 
 
 
 
 
 
 
 
fMI case fatality after day 28 
 
Cox proportional hazard regression was used to estimate HRs of death due to MI after 
diagnosis of fMI in terms of education and sex. There were 37,416 and 25,122 cases of 
MI-specific deaths among men and women, respectively. Overall, multivariable-
adjusted survival was lower in men than in women (HR 1.15, 95% CI 1.13–1.17). 
Patients with a low level of education had approximately a 50% statistically 
significantly worse prognosis compared with those with more than 12 years of 
education regardless of sex and country of birth (Tables 6.1.3). When case fatality after 
day 28 due to coronary heart disease/any causes was estimated, the same protective 
effect of high education was found but to a lesser degree (results not shown in tables).   
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Table 6.1.3: Hazard ratio (HR) for death after non-fatal first-time myocardial infarction in 
Sweden, 1987–2008  
 Sweden-born Foreign-born 
Cases PYRS
§ HR* (95% CI) Cases PYRS§ HR* (95% CI) 
       
Men       
Years of education       
   less than 9 19 651 691 668 1.41 (1.34-1.47) 1 105 58 193 1.44 (1.25-1.66) 
   9 to 12 7 783 423 574 1.21 (1.15-1.27) 812 54 750 1.31 (1.13-1.52) 
   more than 12 2 222 153 824 1 222 21 342 1 
    P for trend   <0.001   <0.001 
    unknown 5 278 45 884 1.44 (1.36-1.52) 343 7 710 1.53 (1.28-1.82) 
 
Women       
Years of education       
   less than 9 13 402 407 090 1.54 (1.42-1.66) 965 38 807 1.47 (1.16-1.87) 
   9 to 12 3 181 163 278 1.32 (1.21-1.43) 373 20 889 1.28 (1.00-1.64) 
   more than 12 623 43 552 1 73 5 339 1 
    P for trend   <0.001   <0.001 
    unknown 6 041 55 980 1.65 (1.51-1.80) 464 9 719 1.43 (1.11-1.84) 
§ 
person-years 
* Mutually adjusted for education, age, co-morbidities and calendar years of follow-up when 
applicable. 
Statistically significant IRRs were highlighted.  
 
 
 
5.2 ADMISSION TO CCU (PAPER II) 
Of a total of 199,906 patients who were admitted to hospital after their fMI during the 
years 2001 to 2009, 120,609 patients received treatment in a CCU. The total number of 
fMI patients who were admitted to hospital decreased from 23,356 in 2001 to 19,385 in 
2009. 
 
Logistic regression was used to estimate the likelihood of being admitted to a CCU 
after fMI diagnosis. There was no evidence of an overall association between 
immigration status and the likelihood of treatment in a CCU. Foreign-born fMI patients 
showed equal likelihood of admission to a CCU compared with Sweden-born patients, 
for both men and women. Admission to a CCU was not confounded by the level of 
education and year of diagnosis. 
 
Table 6.2.1: Odds ratio (OR) and 95% confidence interval (CI) of access to a coronary care unit 
(CCU) after first-time myocardial infarction by sex and immigration status in patients living in 
Sweden between 2001 and 2009 
Men Access to CCU 
yes/no 
OR* (95% CI) OR** (95% CI) OR*** (95% CI) 
 Foreign born 10,010/3,893 1.00 (0.96–1.05) 1.01 (0.97–1.06) 0.97 (0.93–1.02) 
 Sweden born 65,215/35,269 1 1 1 
     
Women     
 Foreign born 5,639/3,962 1.03 (0.98–1.08) 1.02 (0.97–1.07) 1.01 (0.96–1.06) 
 Sweden born 39,745/36,173 1 1 1 
* Adjusted for age at diagnosis 
** Mutually adjusted for other variables in the Table 
***Additionally adjusted for medical conditions, and availability of CCU facilities 
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A lower level of education was associated with a decreased likelihood of being 
admitted to a CCU. While education had a borderline significant effect on the 
likelihood of being treated in a CCU among women, regardless of country of birth, the 
OR for treatment in a CCU was 6% lower (OR 0.94, 95% CI 0.90–0.97) among men 
with a low level of education born within Sweden and 14% lower (OR 0.86, 95% CI 
0.78–0.95) among those born outside Sweden, compared with highly educated Sweden-
born and foreign-born men, respectively (Table 6.2.2). 
 
 
Table 6.2.2: Odds ratio (OR) and 95% confidence interval (CI) of access to a coronary care unit 
(CCU) after first-time myocardial infarction by sex and level of education in patients living in 
Sweden between 2001 and 2009 
Men Access to CCU 
yes/no 
OR* (95% CI) OR** (95% CI) OR*** (95% CI) 
 Less than 9 years 34,217/20,468 0.86 (0.83–0.89) 0.89 (0.86–0.92) 0.93 (0.89–0.96) 
 9 to 12 years 19,045/9,226 0.85 (0.82–0.88) 0.86 (0.83–0.90) 0.90 (0.86–0.93) 
 More than 12 years 20,682/7,681 1 1 1 
 Unknown 1,281/1,787 0.67 (0.62–0.73) 0.73 (0.67–0.80) 0.75 (0.69–0.82) 
     
Women     
 Less than 9 years 25,368/24,474 0.88 (0.84–0.93) 0.92 (0.87–0.96) 0.95 (0.90–1.00) 
 9 to 12 years 12,351/8,505 0.93 (0.88–0.98) 0.95 (0.90–1.00) 0.97 (0.92–1.03) 
 More than 12 years 5,990/3,377 1 1 1 
 Unknown 1,675/3,779 0.69 (0.64–0.75) 0.76 (0.70–0.83) 0.80 (0.73–0.87) 
     
     
* Adjusted for age at diagnosis 
** Mutually adjusted for other variables in the Table 
***Additionally adjusted for medical conditions, and availability of CCU facilities. 
Bold numbers indicate statistically significant ORs. 
 
 
In terms of sex difference, the proportion of women treated in a CCU was 13% lower 
than that of men. This lower proportion was consistently observed among both foreign-
born and Sweden-born MI patients; in both groups, female patients had around 10–20% 
lower odds of being treated in a CCU compared with their male counterparts. This 
decreased admission rate was not explained by level of education, medical conditions, 
or hospital characteristics. 
 
The adjusted OR values for patients from individual countries were consistent with the 
results obtained when foreign-born patients as a whole were compared with those born 
in Sweden. There were no statistically significant differences in access to CCU 
treatment among the majority of foreign-born compared to Sweden-born patients. 
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5.3 EVIDENCE-BASED TREATMENTS AFTER FMI AMONG PATIENTS IN 
THE CCU (PAPER III) 
Between January 2001 to December 2009, 120,609 fMI patients were admitted to a 
CCU in Sweden. To allow at least 3 months of follow-up, 3,115 patients with a 
diagnosis after September 30, 2009 were excluded from the analyses. Our final cohort 
thus included 117,494 patients. Of these, 15,174 (12.91%) were born outside Sweden. 
Compared with Sweden-born patients, among foreign-born patients there was an earlier 
onset of fMI, higher proportions of high education level, chest pain at admission, and 
ever or current smokers, and a higher prevalence of diabetes. 
 
 
During the study period there were 72,503 fMI patients (61.71%) who underwent 
angiography within 90 days. The mean delay from admission to angiography was 5.69 
days (SD 13.82 days) among those who underwent the procedure. The proportion 
undergoing coronary angiography increased during the study period and the mean delay 
decreased regardless of sex and country of birth. After adjusting for potential 
confounders, there was no statistically significant difference in the proportions of 
foreign-born and Sweden-born MI patients undergoing angiography during the study 
period. Analyses were further stratified by sex and year of study, and the results were 
basically unchanged. 
 
 
Further, 53,747 fMI patients (45.74%) underwent PCI within 90 days after admission to 
a CCU. The mean delay for PCI was 5.36 days (SD 13.52 days) among those who 
underwent the treatment. As for angiography, the proportion increased in each 
subgroup during the study period and the mean waiting time decreased. After adjusting 
for potential confounders, foreign-born patients had a borderline statistically 
significantly higher rate of undergoing PCI compared to Sweden-born patients (HR 
1.03, 95% CI 1.00–1.05). 
 
Overall, 10,748 fMI patients (9.15%) underwent CABG within 90 days of admission to 
the CCU. Among these patients, the mean delay for CABG was 19.37 days (SD 19.66 
days). After adjusting for potential confounders, foreign-born patients had statistically 
significant higher rates of CABG than those born in Sweden (HR 1.08, 95% CI 1.02–
1.14). 
 
The analyses were further stratified by geographical regions and continents. There was 
no significant regional variation in terms of rates of undergoing angiography and PCI 
(Figures 6.4.1 and 6.4.2). Moreover, we found that the increased rate of undergoing 
CABG was mainly explained by patients from Asia (Figure 6.4.3).  
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Figure 6.4.2: Adjusted Hazard Ratios of undergoing PCI compared with Sweden-born 
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Figure 6.4.1: Adjusted Hazard Ratios of undergoing angiography compared with Sweden-born 
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Figure 6.4.3: Adjusted Hazard Ratios of undergoing CABG compared with Sweden-born 
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5.4 T1DM AMONG IMMIGRANT CHILDREN AND YOUNG ADULTS IN 
SWEDEN (PAPER IV) 
We followed 4,469,671 male and 4,231,680 female children and young adults (aged 0 
to 30 years) living in Sweden at any time between January 1, 1969 and December 31, 
2008. Of these individuals 1,533,082 were immigrants and 1,036,724, were offspring of 
immigrants. In the age group 0 to 14 years, we observed a total of 15,022 cases of 
T1DM among those born in Sweden, 464 cases among immigrants, and 2,308 among 
offspring of immigrants. In the age group 15 to 30 years, the corresponding numbers of 
cases of T1DM were 14,956, 1,491, and 1,600. 
 
Compared with Sweden-born children and young adults, immigrants aged 0 to 14 years 
had about a 40% lower risk of T1DM and offspring of immigrants had about a 25% 
lower risk. Immigrants aged 15 to 30 years had about a 30% lower risk of T1DM and 
offspring of immigrants had about a 15% lower risk compared with their Sweden-born 
counterparts. Analyses stratified by sex showed similar results (Table 5.4). 
 
The effect of parental education was also assessed in the analyses. In the age group 0 to 
14 years, boys with parents with a low level of education (0–9 years) had a 9% 
decreased risk of TIDM (p=0.01) compared with boys with parents with a high level of 
education (at least 13 years), whereas for the same comparison no effect of parental 
education was observed among girls (p=0.08). In the age group 15 to 30 years, 
compared to those with parents with at least 13 years of education, young adults of both 
sexes with parents with <9 years of education had about a 20% increased risk of TIDM. 
 
With a few exceptions, male and female children and young adults born in countries 
within Asia, Southern Europe (except females born in Spain), Eastern Europe, and 
Latin America (except females born in Uruguay), had between 40% and 85% lower 
risks than Sweden-born children/young adults. Similar decreased risks were observed 
among men born in Western Africa and Northern America and in women born in 
Ethiopia, the UK, and Greece. 
 
Based on joint point regression analyses, we found increasing trends for incidence of 
T1DM by year of diagnosis for all levels of parental education in both boys and girls 
younger than 15 years (p<0.001). However, among young adults aged 15 to 30 years, 
the pattern was less clear  
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Table 6.4: Risk of type 1 diabetes mellitus by age group, sex, and immigration 
status in Sweden, 1969–2008 
 Male Female 
 Cases Person-years RRa (95% CI) Cases Person-years RRa (95% CI) 
0-14 years old       
Immigrant     235   1 282 599 0.56 (0.49-
0.64) 
   229   1 294 355 0.58 (0.50-
0.67) 
Offspring 1 194   5 025 007 0.73 (0.69-
0.78) 
1 114   4 763 707 0.76 (0.71-
0.81) 
Swedes 7 937 25 742 314 1 7 085 24 256 394 1 
P for trend   <.0001   <.0001 
       
15-30 years old       
Immigrant 738 3 333 146 0.68 (0.62-
0.75) 
753 3 443 234 0.78 (0.71-
0.86) 
Offspring 912 3 746 826 0.86 (0.80-
0.92) 
688 3 533 440 0.82 (0.76-
0.89) 
Swedes 8 138 29 227 539 1 6 818 27 595 034 1 
P for trend   <.0001   <.0001 
a Mutually adjusted for generation, parental education, age and calendar years of follow-up. 
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6 DISCUSSION 
 
6.1 MAIN FINDINGS 
In the epidemiological study of fMI, we demonstrated a continuing decreasing trend in 
the fMI incidence among men as well as the novel finding of a less pronounced 
decreasing trend among women and foreign-born individuals of both sexes in Sweden 
between 1987 and 2008. A clear reduction in case fatality after non-fatal fMI regardless 
of sex or country of birth was noted.  We further observed that men and women with a 
low level of education regardless of their country of birth had an increased risk of and 
worse prognosis after fMI. More importantly, the number of study subjects and length 
of observation were sufficient to explore the incidence of and survival after fMI within 
geographical regions and individual countries of origins.  An increased risk of fMI 
incidence was evident among patients from Southern and Western Asia, for example 
Bangladesh, Afghanistan, Pakistan, and Iraq. This pattern was clearer for men than for 
women. However the risk of fMI was low in immigrants from Eastern and South-
Eastern Asia, including China, Japan, and Vietnam. Within Europe, a regional pattern 
was also apparent; a slightly increasing trend of fMI risk was noted from south to north 
and from west to east. Another region with low fMI risk was Latin America, including 
in Bolivia, Peru, and Chile. These differences were not explained, as in Sweden, by 
differences in SEP, age, and risk factor distribution.  
 
We also found that, among hospitalized fMI patients, the probability of being treated 
within CCUs was equal among immigrants and Sweden-born patients. Although an 
increasing proportion of fMI patients were treated in a CCU between 2001 and 2009, 
inequity still exited for female patients and patients with a lower education level; this 
pattern was observed among both Sweden-born patients and immigrants. The inequity 
was not explained by differences in age, hospital type, or medical conditions such as 
history of diabetes, hyperlipidemia, and atrial fibrillation. The large study cohort also 
allowed us to study inequity of admission to CCUs by regions and individual countries 
in which immigrants were born. Consistent with overall equity of admission to CCUs, 
there was essentially no evidence of inequity based on country of birth. 
 
Among fMI patients admitted to CCUs between 2001 and 2009, the adjusted rates of 
undergoing coronary angiography and PCI were similar between foreign-born and 
Sweden-born patients. A higher proportion of foreign-born patients received CABG 
compared with those born in Sweden and the inequality reduced for women but not for 
men at the end of study period. Higher proportions of female patients from Iraq, State 
of Palestine, and Poland received PCI compared with women from other countries 
including those born in Sweden. Moreover, we found that the increased rate of 
undergoing CABG for foreign-born patients was mainly explained by those from Asia 
and some European countries, for example men from India, Sri Lanka, and State of 
Palestine, women from Syria, Iraq, and Turkey, and both groups from Finland and the 
former Czechoslovakia. 
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In the epidemiological study of T1DM, we found an increasing trend among children 
younger than 15 years of age, but not among those who were 15 to 30 years old during 
the study period between 1969 and 2008. In comparison with Sweden-born individuals, 
the overall risk of T1DM was lower among those born outside Sweden, and to a lesser 
extent among offspring of immigrants. These patterns of decreased risk were more 
pronounced among children than among young adults and were present for both sexes 
and most countries of birth. We further found a reduced risk with increasing parental 
education among young adults but not among children. The variations in risk of T1DM 
over time and generations suggest that the lower risk in male and female immigrants 
and their offspring cannot be explained solely by genetic differences. Individuals born 
in Sweden were among those with the highest risk of T1DM; in general male and 
female children and young adults born in countries within Asia, Southern Europe, 
Eastern Europe, and Latin America had statistically significantly lower risks than 
Sweden-born children and young adults.  
 
6.2 RESULTS IN RELATION TO PREVIOUS RESEARCH 
 
6.2.1 Paper I 
Our findings of a negative association between SEP, measured as the highest level of 
education attained, and incidence of and survival after fMI confirmed SEP as an 
important MI risk indicator
24, 142, 143
. The increased MI incidence among individuals 
with lower educational levels were, however, relatively stronger for women than for 
men and for Sweden-born than for foreign-born populations. The poorer prognosis 
among fMI patients with a low level of education was similar for both sexes and not 
afftected by immigration status. Education might have an impact on risk of fMI 
indirectly via known MI risk factors that were not evaluated in our study, such as 
smoking
1, 144
, obesity
144
, prolonged exposure to heavy alcohol consumption
145
, and high 
cholesterol levels
146
. Moreover, healthcare-seeking behavior, treatment, and lifestyle 
awareness between populations with different levels of education might partially 
explain the different prognosis among patients. Lack of reliable information on these 
important lifestyle risk factors especially among immigrants in Sweden is a limitation 
of our study.  
 
We found that, at present, the multivariable-adjusted risk of fMI is continuing to 
decrease among men irrespective of immigration status. This is in accordance with 
results of previous studies showing decreased MI trend during the earlier years up to 
2004
147
. For women, however, the incidence rate decreased at a slower pace than for 
men. One possible explanation for this gender difference could be that the prevalence 
of certain MI risk factors varies among men and women. For example, smoking has 
historically been more common in men than women
1
 but there seems to be an altering 
trend of an increasing prevalence in women with a decreasing rate in men
93
. The 
increasing fMI incidence around the year 2001 might be explained by a change in 
diagnostic criteria that were introduced in 2000 in Sweden. The main change was 
inclusion of the new criterion of raised troponin T concentration in addition to other 
factors. Some patients who were classified as having unstable angina according to 
previous diagnostic guidelines would have been diagnosed with MI since 2000
135
. 
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The increased fMI incidence rate among men and women born in Southern and 
Western Asia was found in many previous studies conducted in North America and 
Sweden
148
. There were minimal difference in incidence rate between immigrants born 
within Europe and Sweden-born individuals. The approximately 10% increased risk 
among Finnish immigrants compared with Sweden-born patients in our study was 
significantly lower than the 70% increased risk observed in another Swedish study
147
.  
A possible explanation for this difference could be that the two studies were conducted 
during different time periods; the previous study was conducted from 1974 to 1976. 
 
6.2.2 Paper II 
The lower rate of treatment in a CCU among women compared with men observed in 
this study has previously been reported in the USA, UK, and Italy
149-152
 and in some 
small regional studies in Sweden
153-155
. We confirmed this finding even after taking 
into account age, educational level as an indication of SEP, country of birth, and a 
number of other potential confounders. A possible explanation for this finding is that 
the predominant symptoms of MI in women might be different from those in men. It 
has been shown that women on average have a lower prevalence of chest pain, which is 
a hallmark symptom among men with MI
156
. Instead, female MI patients might be 
more likely to experience fatigue, neck pain, syncope, nausea, right arm pain, dizziness, 
jaw pain, shortness of breath, and weakness
156, 157
. Women also likely have a different 
attitude toward seeking medical care, such as delaying consultation with healthcare 
professionals
158
. This is important and should be taken into consideration as it may 
result in patient- and healthcare-related delays in the diagnosis of MI to a stage when 
referral to the CCU is not feasible.  
 
In contrast to the findings of studies conducted in countries other than Sweden
159-162
, 
we observed equity of admission to CCUs among Sweden-born and foreign-born fMI 
patients. This was also true when foreign-born patients were further categorized by 
individual country of birth. Moreover, the equity was evident across all study periods. 
The almost cost-free healthcare system for all residents in Sweden might partly explain 
the equal likelihood of being admitted to a CCU for foreign-born and Sweden-born MI 
patients.  
 
6.2.3 Paper III 
In the study of access to cardiac procedures after fMI, there were some similarities 
between our results and those of other international studies even though the 
composition and history of immigrant populations vary across countries. Immigrants 
from Southern Asia tended to have higher rates of cardiac procedures than white 
patients in a study based on 10,308 civil servants in London, UK
163
. Non-English 
speaking populations had higher rates of CABG than native English speakers in public 
hospitals in Victoria, Australia
164
. Another study in Canada showed higher rates of use 
of revascularization among new immigrants
165
. By contrast, some studies conducted 
outside Sweden showed that certain ethnic minority groups had lower rates of 
undergoing cardiac procedures than white patients
160
. The explanation for this 
inconsistency might be that we used country of birth rather than ethnicity or race in our 
study. Being born in a foreign country does not necessarily entail a racial difference or 
other ethnicity. Foreign-born patients in our study included white, black and other 
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racial groups. In addition, patients born in other Nordic regions were also considered to 
be foreign born. Our definition of foreign born was similar to the definition of 
immigrant, or classification by language and world region of origin. Moreover, 
historical immigration patterns, the healthcare system, and healthcare financing 
differences might explain the differences in results
166
.   
 
6.2.4 Paper IV 
The finding in this study of an increasing rate of T1DM incidence among children 
younger than 15 years of age is further evidence of the well-known global rapid rise in 
T1DM risk during the past few decades
54, 167
 and consistent with studies from many 
other countries
168, 169
. This indicates that there is considerable opportunity for 
environmental factors to influence genetic predisposition, for example by changing 
lifestyle. Various factors in early life, such as rapid fetal growth, viral infection during 
pregnancy, preeclampsia, caesarean section delivery, older maternal age, high birth 
weight, and early introduction of cow’s milk proteins170, 171, might be associated with 
the increasing trend of T1DM among children younger than 15 years.  Studies show 
that genetically non-susceptible individuals are more prone to being affected by 
environmental factors than those genetically susceptible to T1DM
172, 173
. 
 
The observed low T1DM incidence rate among immigrants and the slightly increased 
rate among their offspring highlight the importance of lifestyle and environmental 
factors in the etiology of T1DM. In addition, the pronounced lower risk of T1DM 
observed among children of immigrants compared with young adult immigrants also 
suggests the influence of environmental factors. In agreement with our findings, some 
previous studies demonstrated that children of immigrants from countries with a low 
incidence of T1DM retained the incidence close to that of their parents’ countries of 
origin
174-177
, whereas other studies found the opposite
108, 178
 or detected no effect of 
migration
178, 179
. In a study of T1DM in Jewish Ethiopian immigrants in Israel, it was 
argued that adoption of a Western lifestyle, with increasing exposure to diabetogenic 
factors over time, could have contributed to the increased incidence of the disease in 
genetically predisposed individuals
180
.  
 
6.3 METHODOLOGICAL CONSIDERATIONS 
The major strengths of our studies are first the large study population, which provides 
high statistical precision and secondly the nationwide design with a long follow-up 
period including all Sweden-born and foreign-born Swedish residents. Thus it was 
possible to explore the strength of associations and trends with adjustment for several 
confounding factors and effect modifiers between study exposures and outcomes with 
retained statistical power. 
 
Furthermore, the register-based information is of high quality. We had almost complete 
information on the main exposure of the study: country of birth. From 2001 onwards, 
the Swedish National Patient Register included information on hospitalized patients as 
well as outpatient visits to specialist care and day care visits to hospitals throughout 
Sweden. It has been shown that it is reasonable to identify MI cases
181
 and coronary 
risk factors such as diabetes
182
 in this way. The information on diagnosis has been 
validated and in general found to be of high quality, and particularly suitable for large-
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scale population-based research with long follow-up
119
. In 2010, based on 132 
reviewed papers, the positive predictive value of the Swedish National Patient Register 
was found to be about 85% to 95%
119
. The drop-out rate of this register for 2007 has 
been estimated to be less than 1%
118
.The coverage of CCU admissions by means of 
RIKS-HIA is high and is estimated to be at least 95% of all admissions
126, 183
. 
 
Migration is not a random process; immigrants are usually self-selected. Thus, 
immigrants in Sweden might not be representative of the general populations in their 
countries of origin. For example, immigrants might be from particular geographical 
areas such as cities or have particular socioeconomic backgrounds (e.g. students, 
businessmen, or refugees) which might vary by country of origin, time of immigration, 
and reason of immigration. When interpreting study findings regarding the risk of 
certain diseases, these potential differences should always be considered. 
 
Some studies showed a ‘healthy migrant effect’184. That is, migrants are on average 
healthier than the general population of their country of origin. For instance, Turkish 
immigrants in Germany were found to have a lower risk of mortality compared with the 
general population in their home country
185-187
. Some explanations have been proposed 
for this phenomenon. Migration requires good resources and energy that overall 
healthier individuals may possess. Also, immigration host countries often impose health 
criteria that screen out those potential immigrants with certain health issues. However, 
many other studies showed that the so-called healthy migrant effect varies depending 
on the health outcome, host country, and immigrant subpopulation, and thus the 
validity of this effect remains unclear
187, 188
. Therefore, the findings in this thesis cannot 
be extrapolated to the general population of immigrants’ countries of origin. 
 
When measuring the effect of country of birth, several variables that are associated with 
both exposures and outcomes might be considered as confounders. Two of the most 
commonly considered confounders in epidemiological research are age and calendar 
year of diagnosis. Different age distribution between foreign-born and Sweden-born 
populations might be a strong confounder that biases the estimation of risk comparison. 
For example, if the foreign-born population in Sweden was on average much younger 
than the Sweden-born population, it would be expected that the former would have a 
lower incidence rate of MI due to the positive association between fMI risk and age. 
This decreased risk is only comparable for populations in the same age group or with 
the same age group distribution. Similarly, for the year of diagnosis, in order to control 
for the potential difference, either age standardization or age adjustment can be used. In 
this thesis, the temporal trends of fMI and T1DM were controlled for foreign-born and 
Sweden-born populations by age standardization; in the analyses of IRRs, age 
adjustment was used.  
 
Geographical difference within Sweden is another potential source of confounding. It is 
possible that, within a country, the population living in different regions might have 
different risks of diseases
189, 190
. This is particularly relevant when studying admission 
to healthcare. Immigrants seldom settle in the host country homogeneously; they are 
likely to live in large cities, for example where there are more job opportunities. In this 
thesis, overall risk differences have only been estimated at the country level. Further 
research could be conducted to compare differences at the regional level. 
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SEP is one of the study exposure variables and also an important confounder in the 
analysis of country of birth effect. SEP is a subjective measurement. Many researchers 
use education, income, or occupation as indicators of SEP in epidemiological studies. 
All indicators have their own limitations. For example, within the same occupation, 
some individuals work as common clerks whereas others work as managers; this might 
have a very different impact on many health outcomes. Even working in the same 
occupation and in a similar position, working during the day might have a different 
health impact compared with working at night. Income as an indicator of SEP also has 
its limitations. During a long-term follow-up cohort study, income might change over 
the study period. However, it is difficult to model such changes over time. In addition, 
many immigrant families might not have a high income from the new host country, but 
may have savings from their previous life experiences in their countries of origin. We 
believe that education is the most suitable indicator with regard to the study outcomes 
and exposures for several reasons. First, health awareness is more closely associated 
with health outcomes than income and education level, especially in an almost free 
healthcare society such as Sweden. Secondly, it is easier to measure and classify the 
level of education than other indicators since it is more standardized and rarely changes 
after a certain age. In Sweden, there is relatively complete coverage regarding years of 
education for both Sweden-born and foreign-born populations in LISA and FoB.  
 
There are many other factors that might confound our results. We were able to adjust 
for some but not all of them. For example, in addition to age, calendar year of 
diagnosis, and SEP, we considered history of diabetes, hypolipidemia, and hypotension 
in the analysis of fMI risk and case fatality (Paper I). In the study of admission to the 
CCU for hospitalized fMI patients (Paper II), we also considered medical conditions 
including diabetes, hypertension, and hyperlipidemia, as well as a history of stroke, 
heart failure, angina, atrial fibrillation, pulmonary embolism, chronic obstructive lung 
disease, and cancer. In the study of access to cardiac procedures after fMI (Paper III), 
the high-quality and wide coverage of RIKS-HIA enabled more potential confounders 
regarding medical information to be considered. Such potential confounders were 
classified as admission information, clinical information during hospitalization, and 
complications during treatment. Admission information included use of angiotensin-
converting enzyme inhibitors at admission, arrival at hospital by ambulance or not, 
beta-blocker use prior to admission, cardiac shock at admission, QRS complex, rhythm, 
and ST and T (ST–T) wave changes on ECG, type of MI, previous PCI, presenting 
symptoms, prior cardiac surgery, pulmonary rate, smoking status, and statin use before 
hospitalization. Clinical information during hospitalization included beta-blocker use 
during treatment, diuretic treatment, and anticoagulant therapy. Complications during 
treatment included AV block, myocardial re-infarction and new fibrillation or flutter 
during hospitalization. In the study of T1DM (Paper IV), we considered parental SEP 
as a potential confounder as participants were aged from 0 to 30 years.  However, the 
M&H Co did not include information on certain lifestyle factors such as smoking, 
physical activity, and alcohol consumption. Many other psychosocial factors such as 
social networks and stress were also not available. Even after adjustment in the models 
for these potential confounders, residual confounding existed. For example, we 
obtained history of hypertension information from the National Patient Register 
(Papers I, II, and III). Those patients with hypertension but never hospitalized would be 
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missing from the cohort. Thus, this limitation should be considered in interpreting the 
results. 
 
Overall, the quality of Swedish registers is high in terms of exposures and outcomes in 
the present studies as mentioned previously. However, in terms of migrant studies, 
there were still many limitations. For example, the date of immigration to Sweden was 
missing for a small proportion of immigrants registered in the Total Population 
Register. In the calculation of follow-up person-years, for these immigrants we instead 
used the first date that appeared in any register as an approximation of their first 
immigration date. Moreover, in calculating the number of person-years of follow-up, it 
was assumed that immigrants lived in Sweden until their emigration or the end of the 
study. However, this might not be the case for some immigrants; it is possible that they 
moved back and forth during the follow-up period. This is similarly also a potential 
problem for Sweden-born individuals. It is possible that some our study incidence 
occurred overseas during their travelling and we did not have this information 
registered in Sweden. It is also possible that both foreign-born and Sweden-born 
individuals emigrated from Sweden but with a delay in reporting this information to 
registers. The evaluation of trends may be affected by another limitation related to data 
quality. The completeness of the coverage of the Patient Register is increasing over 
time. Therefore it would be reasonable to assume that there were more missed cases in 
the earlier period of follow-up compared with the later study period. This potential 
limitation should be considered in interpretation of the study results, particularly with 
regard to increasing trends.  
 
In the study of risk of T1DM, we lacked specific ICD codes to distinguish between 
type I and type II diabetes before 1997. To overcome this limitation, we restricted our 
study population to individuals younger than 30 years in whom diabetes is most likely 
to be type I disease
191-193
. In addition, the results for sensitivity analyses of data from 
the period 1997–2008 (during which time specific ICD codes for T1DM were 
available) were similar to the results for the entire study period. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
6.4 CONCLUSIONS 
1) The fMI incidence rate in Sweden is decreasing, but this pattern is less evident 
for women and foreign-born individuals.  
2) A clear improvement in prognosis after non-fatal fMI is evident for both 
Sweden-born and foreign-born men and women. 
3) Low education level is associated with increased fMI risk and worse prognosis 
after fMI. 
4) Men and women born in Southern and Western Asia who immigrated to 
Sweden have a high incidence rate of fMI.  
5) The proportion of fMI patients treated in CCUs has been increasing during the 
past decades. However women and less well educated fMI patients have a 
lower chance of admission compared with men and those with a high level of 
education, respectively.  
6) Foreign-born and Sweden-born patients are equally likely to be admitted to a 
CCU after fMI. 
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7)  The overall rates of undergoing coronary angiography and PCI are similar 
between foreign-born and Sweden-born patients, but are higher among those 
with a low compared to a high level of education. 
8) Foreign-born MI patients undergo CABG at a higher rate compared with 
Sweden-born patients, with those born in Asia having the highest rate. 
9) The incidence of T1DM is increasing among children younger than 15 years of 
age, but not among young adults. 
10) Compared with Sweden-born individuals, the risk of T1DM is decreasing 
among immigrants and to a lesser degree also among offspring of immigrants. 
This decreased risk is more pronounced among children than among young 
adults for both sexes and for most countries of birth. The changes in risk over 
time and generations indicate that the low risk of T1DM in immigrants and their 
offspring cannot only be explained by genetic factors. 
 
6.5 FUTURE RESEARCH 
Based on the findings of this thesis, nested case–control studies could be designed in 
order to further understand the relation between migration and health outcomes. 
Important potential confounders, such as history of smoking and alcohol consumption, 
family history of various diseases, stress, diet, childhood lifestyle, and many others 
could be considered in future. 
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